News & Analysis on Clinical Trial Services & Contract Research And Development
NextPharma: acquisition of two Lonza sites
By Jenni Spinner
- Last updated on
NextPharma has agreed to purchase two Lonza sites. The Ploermel, France, and Edinburgh, UK sites currently produce liquid-filled hard capsules and softgels for the pharmaceutical and consumer health and nutrition markets.
Peter Burema, CEO of NextPharma, said, “These technologies, combined with the know-how and expertise of the employees at both sites, would provide additional solutions for drug formulations which will benefit patients across the world.”